RTS,S
MALARIA VACCINE
Mosquirix; RTS,S vaccine; Recombinant malaria vaccine; RTS,S/AS01
RTS,S/AS01 (trade name Mosquirix) is a recombinant protein-based malaria vaccine. In October 2021, the vaccine was endorsed by the World Health Organization (WHO) for "broad use" in children, making it the first malaria vaccine candidate, and first vaccine to address parasitic infection, to receive this recommendation.